FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

BERGER HARVEY J M D
2. Issuer Name and Ticker or Trading Symbol

ARIAD PHARMACEUTICALS INC [ ARIA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman & CEO
(Last)          (First)          (Middle)

C/O ARIAD PHARMACEUTICALS, INC., 26 LANDSDOWNE STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

3/19/2014
(Street)

CAMBRIDGE, MA 02139
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/19/2014     M (1)    36000   A $0   1086759   D    
Common Stock   3/19/2014     F    11711   (2) D $8.19   1075048   D    
Common Stock   3/20/2014     M (3)    34000   A $0   1109048   D    
Common Stock   3/20/2014     F    11084   (2) D $8.13   1097964   D    
Common Stock                  246054   I   Daughter  
Common Stock                  248745   I   Daughter  
Common Stock                  1714286   I   Ocean Capital Partners, Llc   (4)
Common Stock                  0   I   Trust  
Common Stock                  245251   I   Wife  
Common Stock                  0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units     (5) 3/19/2014     M         36000      (6) 3/19/2023   Common Stock   36000   $0   72000   D    
Restricted Stock Units     (5) 3/20/2014     M         34000      (7) 3/20/2022   Common Stock   34000   $0   34000   D    

Explanation of Responses:
( 1)  Shares were acquired upon vesting of restricted stock units awarded on March 19, 2013.
( 2)  Represents shares withheld to satisfy withholding tax requirements.
( 3)  Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
( 4)  The reporting person is a managing member of this LLC.
( 5)  Each restricted stock unit represents a right to receive one share of ARIAD common stock.
( 6)  The restricted stock units vested on March 19, 2014.
( 7)  The restricted stock units vested on March 20, 2014.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
BERGER HARVEY J M D
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
X
Chairman & CEO

Signatures
/s/Edward M. Fitzgerald, Attorney-in-Fact 3/21/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Ariad Charts.
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Ariad Charts.